On Monday, Warren Resources, Inc. (NASDAQ:WRES)’s shares declined -7.02% to $1.06.
Warren Resources, Inc. (WRES) will report first quarter 2015 financial results on Thursday, May 7, 2015 by issuing a press release before the market opens and conducting a conference call on that date at 11:00 a.m. Eastern Time. The full text of the release will be accessible at warrenresources.com under “For Investors — News & Events”. The conference call will also be broadcast live over the Internet and can be accessed by registering at warrenresources.com under “For Investors”.
Warren Resources, Inc., an independent energy company, engages in the exploration, development, and production of domestic onshore crude oil and gas reserves.
Horizon Pharma PLC (NASDAQ:HZNP)’s shares dropped -6.93% to $29.55.
Horizon Pharma PLC (HZNP) declared that Timothy P. Walbert, chairman, president and chief executive officer, was elected to the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA).
PhRMA represents the country’s leading biopharmaceutical research and biotechnology companies, and is devoted to advancing public policies in the Unites States and around the world that support innovative medical research, yield progress for patients recently and provide hope for the treatments and cures of tomorrow.
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally.
At the end of Monday’s trade, Cinedigm Corp (NASDAQ:CIDM)‘s shares dipped -6.92% to $0.885.
Cinedigm Corp (CIDM) will host a conference call for investors to talk about the recent private offering of 5.5% convertible senior notes due 2035 on Wednesday, April 29, 2015 at 4:30 p.m. EDT.
Cinedigm Corp. distributes independent movie, television, and other short form content in the Unites States. It manages a library of distribution rights to about 52,000 titles and episodes released across theatrical, digital, physical, home, and mobile entertainment platforms, in addition to services digital cinema assets on about 12,000 movies screens.
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA), ended its Monday’s trading session with -6.80% loss, and closed at $9.05.
Ariad Pharmaceuticals, Inc. (ARIA) declared that it will report its first quarter 2015 financial results on Thursday, May 7, 2015, before the market opens. Following the declarement, at 8:30 a.m. Eastern Time, company administration will host a conference call and webcast talk aboution of the results and provide a general corporate update.
ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult patients with chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia in the United States, Europe, and other territories.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
